Searched for
PATIENT VOLUMES GROWTH
Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 targetMotilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expans...- Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: StudyThe Ayush services sector is projected to reach USD 216-318 billion by 2047 as it continues to expand. This sector reported a 16.91 percent...
- The 30-Minute Medicine ProblemHow India's largest ePharmacy is building an in-house quick-commerce engine across cities and why moving medicines in under an hour is far ...
- Cannot rest on tailwinds, have to be conscious of risks, says PM's Principal SecretaryMishra listed fragmented global alliances, dependence on imports, pressure on the country's external accounts and artificial intelligence a...
- Short-term headwinds, long-term calm: 6 mid-cap stocks from different sectors with upside potential of up to 22%This is not the time to expect that every stock you own will do well; or that you will make quick and easy gains. If you are entering the m...
- India’s chip push draws global interest; Quick comm's ad blitzIndia’s semiconductor push is gaining global attention as the country looks to build a stronger chip manufacturing ecosystem. This and more...
- Advent International joins India’s hospital gold rush with Rs 3,150 crore Yatharth betAdvent International will invest Rs 3,150 crore in Yatharth Hospitals for a significant stake. This marks one of the largest private equity...
- Why Jefferies is bullish on Manipal Hospitals after its ₹9,000 crore acquisition spreeManipal Hospitals’ acquisition-led expansion is entering a key phase, with Jefferies initiating coverage with a Buy rating and Rs 870 targe...
- Nike’s shoe doesn't fit: How did the swoosh lose its winning edge?Nike’s decline is raising questions about how the sportswear giant lost its competitive edge. Falling revenue, a collapsing market value, w...
- Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 marketsNovartis India plans acquisitions and deeper market penetration for future growth. The company will focus on five key therapy areas for exp...
- NSE's unlisted shares down 17% from peak ahead of IPO; BSE falls 29%. Which is a better bet right now?NSE is inching closer to its much-awaited IPO as SEBI nears approval of its DRHP. While unlisted NSE shares remain 17% below their peak, BS...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
- In 1940, scientists had no fermentation tanks, so penicillin was grown in hundreds of ceramic vessels modeled on hospital bedpans; the improvised system helped turn Fleming’s discovery into a mass-produced medicineIn 1940, scientists working to develop penicillin faced a major obstacle: they had discovered a potentially lifesaving medicine but lacked ...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- Apollo Hospitals Q1 Results: Net profit jumps 38% YoY to Rs 610 crore; revenue rises 21%Apollo Hospitals reported a 38.4% year-on-year rise in Q1FY27 net profit to ₹610 crore, while revenue grew 20.6% to ₹7,044 crore. EBITDA in...
- Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellersDr Agarwals Health Care shares dropped on Wednesday after a Rs 2,065-crore block deal involving 4.07 crore shares. Hyperion Investments and...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- KKR to acquire Medicover India in $1.5 billion dealThe transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth ...
- IndiGo's next flight plan: Airline targets bigger global push, diaspora traffic through IndiaIndiGo marks twenty years by planning a significant international expansion. The airline will induct new aircraft to connect the global Ind...
Load More
